Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1855]
News [2824]
Articles [214]
Editorials [1]
Conferences [142]
elearning [13]
Compound improves survival in aggressive acute myeloid leukaemia with...
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
7 Dec 2014
ASH 2014: Expert discussion on the latest in AML
Prof Alan Burnett and Prof Sergio Amadori
ASH 2014: Expert discussion on the latest in AML ( Prof Alan Burnett and Prof Sergio Amadori )
7 Dec 2014
ASH 2014: Expert discussion on the latest in CLL
Prof John Gribben and Prof Stephan Stilgenbauer
ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )
7 Dec 2014
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Post-transplant survival boosted by brentuximab vedotin in lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
6 Dec 2014
ecancermedicalscience editor's choice for November 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for November 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
28 Nov 2014
Overcoming cancer resistance with enzyme inhibitors
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Overcoming cancer resistance with enzyme inhibitors ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
27 Nov 2014
New emerging treatments and challenges in MCL, MM and CLL: Expert panel...
Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo
New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion ( Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo )
24 Nov 2014
Fly models and genome sequencing
Dr Ross Cagan - Mount Sinai School of Medicine, New York, USA
Fly models and genome sequencing ( Dr Ross Cagan - Mount Sinai School of Medicine, New York, USA )
11 Nov 2014
The role of NCRI in promoting collaborative research initiatives
Dr Karen Kennedy, Director of NCRI, UK
The role of NCRI in promoting collaborative research initiatives ( Dr Karen Kennedy, Director of NCRI, UK )
10 Nov 2014
Age and chemotherapy choices: risk factors versus benefit?
Dr Christos Markopoulos - Athens University Medical School, Athens, Greece
Age and chemotherapy choices: risk factors versus benefit? ( Dr Christos Markopoulos - Athens University Medical School, Athens, Greece )
10 Nov 2014
Challenges of adjuvant chemotherapy in older breast cancer patients
Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Challenges of adjuvant chemotherapy in older breast cancer patients ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
10 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation